sarcopenic obesity
Selected indexed studies
- Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management. (Front Endocrinol (Lausanne), 2023) [PMID:37455897]
- Sarcopenic obesity in older adults: a clinical overview. (Nat Rev Endocrinol, 2024) [PMID:38321142]
- Sarcopenic obesity: emerging mechanisms and therapeutic potential. (Metabolism, 2023) [PMID:37380015]
_Worker-drafted node — pending editorial review._
Connections
sarcopenic obesity is a risk factor for
sarcopenic obesity is caused by
Sources
- Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management. (2023) pubmed
- Sarcopenic obesity in older adults: a clinical overview. (2024) pubmed
- Sarcopenic obesity: emerging mechanisms and therapeutic potential. (2023) pubmed
- Sarcopenic obesity: a review. (2025) pubmed
- Sarcopenia and sarcopenic obesity. (2016) pubmed
- Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines. (2022) pubmed
- Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments. (2020) pubmed
- The Diagnosis and Treatment of Sarcopenia and Sarcopenic Obesity. (2025) pubmed
- Sarcopenic obesity in cancer. (2024) pubmed
- Associations between sarcopenic obesity and risk of cardiovascular disease: A population-based cohort study among middle-aged and older adults using the CHARLS. (2024) pubmed